zyprexa

Showing 9 posts of 9 posts found.

Lilly image

Lilly and Novartis face legal challenges

June 25, 2015
Medical Communications, Sales and Marketing Gleevec, Glivec, Novartis, cymbalta, imatinib, lilly, zyprexa

Judges in California have ruled that Lilly should face claims it failed to fully disclose the extent of post-withdrawal side …

Lilly image

Lacklustre sales hit Lilly again

October 24, 2014
Sales and Marketing Q3, cymbalta, humilin, lilly, sales, zyprexa

Lilly is enduring one of the bleakest financial years in its history as patent expiries continue to take chunks out …

Lilly image

Lilly to go ‘on offense’

January 31, 2014
Sales and Marketing Alimta, Lechleiter, cymbalta, lilly, q4, zyprexa

The loss of patent on antidepressant Cymbalta in the US last December was largely responsible for Eli Lilly & Co’s …

Lilly image

Lilly beats estimates with solid Q2 performance

July 26, 2013
Sales and Marketing Q2, cymbalta, lilly, zyprexa

Lilly posted a healthy set of financials at the end of July as the company looks to keep its growth …

lilly_corporate_hq

Zyprexa decline hits Lilly

April 26, 2013
Sales and Marketing Q1, lilly, zyprexa

Loss of exclusivity on Lilly’s blockbuster antipsychotic Zyprexa in 2011 continued to hit the company hard in the first quarter …

Lilly hit by Zyprexa losses

January 30, 2013
Sales and Marketing antipsychotic, lilly, zyprexa

The loss of exclusivity on Eli Lilly’s blockbuster antipsychotic Zyprexa hit the company hard in 2012, with the firm’s overall …

Lundbeck launches bipolar drug Sycrest in the UK

January 17, 2012
Sales and Marketing Lundbeck, Saphris, Sycrest, zyprexa

Lundbeck has launched Sycrest in the UK for the treatment of acute attacks of bipolar I disorder. Sycrest (asenapine) is …

lilly_entrance_web

Lilly pessimistic on 2012 performance

January 6, 2012
Sales and Marketing Eli Lilly, lilly, zyprexa

Lilly is forecasting a drop in revenue and profits for 2012, as it prepares for life without its blockbuster antipsychotic …

New products behind Lilly growth

October 19, 2007
Sales and Marketing lilly, zyprexa

Sales rose 19% for Lilly in the third quarter of the year, with depression treatment Cymbalta leading the growth in …

The Gateway to Local Adoption Series

Latest content